Bone density is normal and does not change over 2 years in sarcoidosis

Area of Science:

• Rheumatology
• Endocrinology
• Pulmonology

Background:

• Previous studies suggested a link between sarcoidosis and low bone mineral density (BMD).
• Sarcoidosis is a systemic inflammatory disease that can affect multiple organs.

Purpose of the Study:

• To investigate bone mineral density (BMD) in patients with sarcoidosis.
• To determine if sarcoidosis is associated with accelerated bone loss over time.

Main Methods:

• Observational study of 64 sarcoidosis patients.
• Cross-sectional assessment of BMD at baseline.
• 1-year intervention study with vitamin D supplements for 27 patients.
• 2-year longitudinal study of BMD for 37 patients.

Main Results:

• At baseline, BMD was within normal population ranges, with some sites showing higher than expected values.
• No significant change in BMD was observed at the lumbar spine, total hip, or femoral neck over 2 years.
• Vitamin D supplementation did not impact BMD.
• A slight decrease in total body BMD was noted over 1 year.

Conclusions:

• Bone mineral density (BMD) in sarcoidosis patients is generally normal at baseline.
• There is no consistent evidence of accelerated bone loss in sarcoidosis patients over 1-2 years.
• Routine BMD monitoring is not recommended for sarcoidosis patients not on oral glucocorticoids.